EEEdzel Evallo

Edzel Evallo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Edzel Evallo has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Adipocyte-specific MC2R overexpression exerts minimal metabolic effects in mice

    by Sangyi Lim, Edzel Evallo, Dong-Il Kim, Min-Jung Park

    Background: Obesity is often associated with elevated glucocorticoid (GC) levels mediated by melanocortin 2 receptor (MC2R), the adrenocorticotropic hormone (ACTH) receptor expressed in the adrenal gland. Meanwhile, previous in vitro studies in non-adrenal cells suggest a potential role for MC2R in lipid metabolism in murine primary adipocytes; however, the functional relevance of MC2R in vivo remains poorly understood. Here, we assessed the metabolic effects and therapeutic potential of MC2R in obesity and GC regulation in vivo by generating mice with adipocyte-specific MC2R overexpression using the adeno-associated virus doublef-floxed inverse orientation (AAV-DIO) system. Results: Our findings show that under basal, high-fat diet (HFD), and stress-induced conditions, MC2R overexpression in adipocytes has minimal effects on thermogenic and lipolytic markers and is insufficient to promote weight reduction in mice. Moreover, adipocyte-specific overexpression of MC2R failed to sequester the ACTH and decrease elevated serum corticosterone levels after exogenous ACTH administration. Conclusions: These findings demonstrate that adipocyte-specific MC2R overexpression does not induce strong metabolic benefits, suggesting that MC2R-directed gene therapy may not be an effective treatment strategy for obesity.

  • Open Access

    Distinct HIF1α and HIF2α functions control skeletal muscle metabolism and erythropoiesis

    by Junhyeong Lee, Merc Emil Matienzo, Sangyi Lim, Edzel Evallo, Yeongsin Kim, Sujin Jang, Keon Kim, Chang Hyeon Choi, Youn Ho Han, Chang-Min Lee, et al.

    Skeletal muscle frequently encounters hypoxic stress, particularly during exercise, but the specific functions of the hypoxia-inducible factors HIF1α and HIF2α within myofibers remain unclear due to the lack of appropriate in vivo models. Here, we generated 3 complementary mouse models, myofiber-specific triple-PHD knockout (PHD mTKO) and inducible myofiber-specific overexpression of stabilized HIF1α or HIF2α, to delineate isoform-specific roles of HIFα signaling in skeletal muscle. HIF1α stabilization increased the proportion of oxidative fibers yet paradoxically impaired exercise capacity and mitochondrial function. In contrast, HIF2α activation protected against diet-induced obesity, improved glucose tolerance, and maintained mitochondrial function without altering fiber-type composition. Notably, HIF2α stabilization markedly elevated erythropoietin (EPO) expression in skeletal muscle and serum. Myofiber-specific deletion of EPO in the PHD mTKO background abolished polycythemia, demonstrating that this phenotype is driven specifically by muscle-derived EPO. Together, these findings uncover distinct roles of HIF1α and HIF2α in regulating muscle metabolism and mitochondrial function and establish the PHD–HIF2α axis as a myofiber-derived driver of systemic EPO production.